Left Behind:  Addressing Health Equity for the Rare Disease Patient Community episode artwork

EPISODE · Sep 9, 2024 · 20 MIN

Left Behind: Addressing Health Equity for the Rare Disease Patient Community

from Rx for Biotech · host Podcast Host Chris Leidli

In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. Tamar discussed her efforts to champion health policy, advocacy, equity, and awareness for rare diseases. Link to NMOSD video mentioned in episode: https://www.youtube.com/playlist?list=PLJQx_6LtucSB9GGeiWTycLm7wjK_LX0ZI

Episode metadata supplied by the publisher feed · Published Sep 9, 2024

Embed this episode

NOW PLAYING

Left Behind: Addressing Health Equity for the Rare Disease Patient Community

0:00 20:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 20 minutes long.

When was this Rx for Biotech episode published?

This episode was published on September 9, 2024.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!